4 news items
Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
PRGO
7 May 24
the Company's ability to obtain and maintain its regulatory approvals; potential costs and reputational impact of product recalls or sales halts
Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
PRGO
7 May 24
success in the self-care industry," said Mr. Khoury. "Perrigo has a strong reputation for delivering high-quality consumer products, and I am
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
PRGO
25 Apr 24
the Company's ability to obtain and maintain its regulatory approvals; potential costs and reputational impact of product recalls or sales halts
Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program
PRGO
27 Feb 24
to obtain and maintain its regulatory approvals; potential costs and reputational impact of product recalls or sales halts; potential adverse changes
- Prev
- 1
- Next